Diana S M Buist
Biographic Data
| ID | 89896 |
|---|---|
| NAME | Diana S M Buist |
| GIVEN NAMES | Diana S M |
| FAMILY NAME | Buist |
| SIGNATURE | BUIST D S M |
| AFFILIATIONS | Kaiser Permanente Washington Health Research Institute |
| ORCID | 0000-0001-5408-2804 |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 2 |
| AUTHOR COUNT | 11 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1999 |
| LATEST PUBLICATION YEAR | 2017 |
| H-INDEX | 1 |
An Electronic Health Record–based Algorithm to Ascertain the Date of Second Breast Cancer Events
OBJECTIVES: Studies of cancer recurrences and second primary tumors require information on outcome dates. Little is known about how well electronic health record-based algorithms can identify dates or how errors in dates can bias analyses. RESEARCH DESIGN: We assessed rule-based and model-fitting approaches to assign event dates using a previously published electronic health record-based algorithm for second breast cancer events (SBCE). We conduc…
Latina and Black/African American Women's Perspectives on Cancer Screening and Cancer Screening Reminders
Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer
PURPOSE: We compared the frequency and sequence of breast imaging and biopsy use for the diagnostic and preoperative workup of breast cancer according to breast magnetic resonance imaging (MRI) use among older women. MATERIALS AND METHODS: Using SEER-Medicare data from 2004 to 2010, we identified women with and without breast MRI as part of their diagnostic and preoperative breast cancer workup and measured the number and sequence of breast imagi…
I Am Pregnant and Want to Do Better But I Can’t: Focus Groups with Low-Income Overweight and Obese Pregnant Women
Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% report…
Effects of Digital Mammography Uptake on Downstream Breast-related Care Among Older Women
BACKGROUND: Digital mammography is the dominant modality for breast cancer screening in the United States. No previous studies have investigated as to how introducing digital mammography affects downstream breast-related care. OBJECTIVE: Compare breast-related health care use after a screening mammogram before and after introduction of digital mammography. RESEARCH DESIGN AND SUBJECTS: Longitudinal study of screening mammograms from 14 radiology …
Assessing Health Care Use and Cost Consequences of a New Screening Modality: The Case of Digital Mammography
BACKGROUND: Full-field digital mammography (FFDM) has largely replaced screen-film mammography (SFM) for breast cancer screening, but how this affects downstream breast-related use and costs is unknown. OBJECTIVES: To compare breast-related health care use and costs among Medicare beneficiaries undergoing SFM versus FFDM from 1999 to 2005. DESIGN: Retrospective cohort study. SUBJECTS: Medicare-enrolled women aged 66 and older with mammograms in B…
An Assessment of the Quality of Mammography Care at Facilities Treating Medically Vulnerable Populations
BACKGROUND: Women in medically vulnerable populations, including racial and ethnic minorities, socioeconomically disadvantaged, and residents of rural areas, experience higher breast cancer mortality than do others. Whether mammography facilities that treat vulnerable women demonstrate lower quality of care than other facilities is unknown. OBJECTIVES: To assess the quality of mammography women receive at facilities characterized as serving a hig…
Impact of Hormone Therapy on False-Positive Recall and Costs Among Women Undergoing Screening Mammography
OBJECTIVE: We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs. DESIGN: We undertook an observational cohort study of women ages 40-80 years with 2 mammography screenings in an integrated delivery system. MEASURES: FP recall, defined as mammograms resulting in a radiologist's recommendation for additional imaging, ultrasound, or invasive procedures among disease-free w…
Evaluation of Three Population-Based Strategies for Fracture Prevention: Results of the Osteoporosis Population-Based Risk Assessment (Opra) Trial
BACKGROUND: The integration of bone density testing into well-designed fracture prevention programs that can be applied in populations has not been studied. OBJECTIVES: We sought to compare the outcomes of 3 strategies for allocating bone density testing within an HMO-based fracture prevention program. RESEARCH DESIGN: Women were randomly sampled and allocated to one of 3 groups: (1) a universal group, in which all were offered bone mineral densi…
Population-based strategy for improving informed decision making about hormone replacement therapy in managed care settings
Population-based strategy for improving informed decision making about hormone replacement therapy in managed care settings
Evaluation of Three Population-Based Strategies for Fracture Prevention: Results of the Osteoporosis Population-Based Risk Assessment (Opra) Trial
BACKGROUND: The integration of bone density testing into well-designed fracture prevention programs that can be applied in populations has not been studied. OBJECTIVES: We sought to compare the outcomes of 3 strategies for allocating bone density testing within an HMO-based fracture prevention program. RESEARCH DESIGN: Women were randomly sampled and allocated to one of 3 groups: (1) a universal group, in which all were offered bone mineral densi…
Impact of Hormone Therapy on False-Positive Recall and Costs Among Women Undergoing Screening Mammography
OBJECTIVE: We sought to evaluate the effects of hormone therapy (HT) on false-positive (FP) recall for additional breast evaluation and costs. DESIGN: We undertook an observational cohort study of women ages 40-80 years with 2 mammography screenings in an integrated delivery system. MEASURES: FP recall, defined as mammograms resulting in a radiologist's recommendation for additional imaging, ultrasound, or invasive procedures among disease-free w…
An Assessment of the Quality of Mammography Care at Facilities Treating Medically Vulnerable Populations
BACKGROUND: Women in medically vulnerable populations, including racial and ethnic minorities, socioeconomically disadvantaged, and residents of rural areas, experience higher breast cancer mortality than do others. Whether mammography facilities that treat vulnerable women demonstrate lower quality of care than other facilities is unknown. OBJECTIVES: To assess the quality of mammography women receive at facilities characterized as serving a hig…
Effects of Digital Mammography Uptake on Downstream Breast-related Care Among Older Women
BACKGROUND: Digital mammography is the dominant modality for breast cancer screening in the United States. No previous studies have investigated as to how introducing digital mammography affects downstream breast-related care. OBJECTIVE: Compare breast-related health care use after a screening mammogram before and after introduction of digital mammography. RESEARCH DESIGN AND SUBJECTS: Longitudinal study of screening mammograms from 14 radiology …
Assessing Health Care Use and Cost Consequences of a New Screening Modality: The Case of Digital Mammography
BACKGROUND: Full-field digital mammography (FFDM) has largely replaced screen-film mammography (SFM) for breast cancer screening, but how this affects downstream breast-related use and costs is unknown. OBJECTIVES: To compare breast-related health care use and costs among Medicare beneficiaries undergoing SFM versus FFDM from 1999 to 2005. DESIGN: Retrospective cohort study. SUBJECTS: Medicare-enrolled women aged 66 and older with mammograms in B…
I Am Pregnant and Want to Do Better But I Can’t: Focus Groups with Low-Income Overweight and Obese Pregnant Women
Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% report…
Breast MRI in the Diagnostic and Preoperative Workup Among Medicare Beneficiaries With Breast Cancer
PURPOSE: We compared the frequency and sequence of breast imaging and biopsy use for the diagnostic and preoperative workup of breast cancer according to breast magnetic resonance imaging (MRI) use among older women. MATERIALS AND METHODS: Using SEER-Medicare data from 2004 to 2010, we identified women with and without breast MRI as part of their diagnostic and preoperative breast cancer workup and measured the number and sequence of breast imagi…
An Electronic Health Record–based Algorithm to Ascertain the Date of Second Breast Cancer Events
OBJECTIVES: Studies of cancer recurrences and second primary tumors require information on outcome dates. Little is known about how well electronic health record-based algorithms can identify dates or how errors in dates can bias analyses. RESEARCH DESIGN: We assessed rule-based and model-fitting approaches to assign event dates using a previously published electronic health record-based algorithm for second breast cancer events (SBCE). We conduc…
Latina and Black/African American Women's Perspectives on Cancer Screening and Cancer Screening Reminders
Medicine (11 works) · Breast cancer (8 works) · Cancer (8 works) · Global Cancer Incidence and Screening (8 works) · Internal Medicine (8 works) · Internal Medicine (7 works) · Mammography (6 works) · Breast imaging (4 works) · Confidence interval (4 works) · Family medicine (4 works)